Wen R, Chen Y, Long J, Huang X, et al. Aggressive progression to EGFR tyrosine kinase inhibitors in advanced NSCLC patients: concomitant mutations, prognostic indicator and subsequent management. J Cancer Res Clin Oncol 2023;149:8307-8316.
PMID: 37074454